Lataa...
Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy
Metastatic castration-resistant prostate cancer is the lethal form of cancer of the prostate. Five new agents that prolong survival in this group have emerged in the past 5 years, and sipuleucel-T is among them. Sipuleucel-T is the only immunotherapy shown to improve survival in prostate cancer. It...
Tallennettuna:
| Julkaisussa: | Core Evid |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4279604/ https://ncbi.nlm.nih.gov/pubmed/25565923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S54712 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|